In sum, the results of this study have yielded initial clues that a de-differentiation process, which enhances cellular plasticity may be exploited therapeutically to enforce the TD of EMT-derived pancreatic cancer cells into non-malignant functional insulin-expressing cells. This evidence concerns the gene INS and pancreatic neoplasm.